SC 13D/AAMENDMENTSYRECIK 0001636282

Spyre Therapeutics, Inc.

Name: SEC EDGAR filing 0001104659-26-115087
Creator: Spyre Therapeutics, Inc.
License: https://www.usa.gov/government-works

5%+ activist stake (SC 13D/A) filed October 9, 2026.

Disclosure of beneficial ownership above 5% with intent to influence company control.

Open the filing on SEC.gov

New to the SC 13D/A? What it is and how to read one

Filing facts

Accession number: 0001104659-26-115087
Filer: Spyre Therapeutics, Inc.
Ticker: SYRE
CIK: 0001636282
Form type: SC 13D/A
Form description: 5%+ activist stake
Filed at: October 9, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 10, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Spyre Therapeutics, Inc.

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1636282/000110465926115087/0001104659-26-115087-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Spyre Therapeutics, Inc. (0001636282) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001104659-26-115087.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.